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Tight junctions are the most apical organelle of the apical junctional complex and are primarily involved in the regulation of paracellular
permeability and membrane polarity. Extensive research in the past two decades has identified not only the individual molecules of the tight junctions
but also their mutual interactions, which are the focus of the present review article. While a complete map of the interactions among the tight junction
molecules is probably far from being complete, the available evidence already allows outlining the general molecular architecture of the tight
junctions. Here, with the aim of gaining deeper mechanistic understanding of tight junction assembly, regulation and function, we have subdivided
the known molecular interactions into four major clusters that are centered on cell surface, polarity, cytoskeletal and signaling molecules.
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Tight junctions (TJ) are composed of several transmembrane
and intracellular molecules. A detailed analysis of the individual
molecules can be found in recent reviews [1–7], as well as in the
accompanying articles by Chiba et al. [8] and Citi et al. [9]. In
this review, we focus on the interactions between the TJ
molecules. For each interaction, we will provide information on
the methodology used for its discovery, the molecular
determinants and the likely functional significance. We have
subdivided all the interactions into four clusters that correspond
to well-defined features of the TJ. In particular, in Section 2, we
examine the interactions of the cell surface molecules, which
ensure intercellular adhesion and regulate paracellular perme-
ability. Then, in Section 3, we describe the interactions within
the molecular system that determines the establishment of cell
polarity and the localized assembly of the TJ. Subsequently, in
Section 4, we analyze the interactions mediated by intracellular
adapter proteins, which mostly connect the surface molecules
with the actin-based cytoskeleton. Finally, in Section 5, we
describe a cluster of interactions that link the TJ with signaling
and trafficking molecules.
2. Cell surface molecules
The most extensively studied cell surface molecules of the TJ
are occludin, as well as the members of the claudin and junc-Fig. 1. Interactions between representative membrane and adapter molecules. The
proteins claudin-1, JAM-A and occludin, as well as their binding sites for the adapttional adhesion molecule (JAM) families. Although these
proteins have different structures and exert different functions,
they display a similar organization, as they interact both with
other cell surface proteins (on the extracellular side) and with
many adapters (on the intracellular side), which in turn link the
surface molecules to the actin cytoskeleton. The extracellular
interactions involve binding to similar molecules either in cis
(on the membrane of the same cell) or in trans (on the membrane
of the contacting cells). Although these interactions are
important in regulating paracellular permeability, they will not
be discussed here, and the reader is referred to specific reviews
[4,10], as well as to the accompanying articles by Blasig et al.
[11] and Yu et al. [12]. A schematic picture of the interactions
between representative membrane and adapter molecules is
shown in Fig. 1.
2.1. Interactions of occludin
Occludin is a four-pass integral membrane protein that inter-
acts with the actin cytoskeleton and with several intracellular
proteins [13]. The interaction of occludin with the cytoskeleton
requires adapters, such as the zonula occludens (ZO) proteins
and cingulin, even though occludin also binds actin directly. In
particular, occludin associates directly with ZO-1 [14], ZO-2
[15] and ZO-3 [16]. The association with ZO-1 and ZO-2
requires the carboxyl terminal portion of the domain E in the
cytoplasmic tail of occludin, which encompasses residues 358-picture shows modular structure and molecular interactions of the cell surface
ers MUPP1 and ZO-1. GUK, guanylate kinase.
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corresponding to the domain E of occludin (fused to glutathione-
S-transferase; GST) binds directly a recombinant construct that
encompasses the guanylate kinase domain and the acidic region
of ZO-1 [17]. In addition to the ZO proteins, another adapter
that binds occludin is cingulin, which is an actin- and myosin-
binding protein, as detailed in Section 4.2. The interaction be-
tween occludin and cingulin, which was detected in the Xenopus
A6 epithelial cells, is direct and requires the carboxyl terminal
region of occludin [18]. Occludin, however, also binds actin
directly, thus providing an example of a direct link between a
junctional cell surface protein and the cytoskeleton. Specifically,
occludin interacts with F-actin in vitro and colocalizes with actin
aggregates at the cell–cell borders in Madin–Derby canine
kidney (MDCK) cells. In the co-sedimentation assay, in which
polymerized actin filaments are pelleted at high-speed centrifu-
gation, GST-occludin co-sediments with F-actin. In addition,
occludin co-sediments with F-actin, when spun through
glycerol, thus indicating that the interaction is not due to the
mechanical trapping of occludin in the meshwork of actin
filaments [19].
In addition to the adapters, occludin associates with enzymes
that induce post-translational modifications of occludin (such as
phosphorylation, dephosphorylation and ubiquitination) during
TJ assembly and disassembly. Specifically, occludin is phosphor-
ylated on either tyrosine or serine/threonine residues [20].
Phosphorylation of occludin on tyrosine involves the non-
receptor kinase c-Yes and likely favors TJ maintenance. Actually,
the complex between occludin and c-Yes dissociates not only
upon treatment with the c-Yes inhibitor CGP77675, but also upon
depletion of extracellular calcium, a treatment that mimics in vitro
the disassembly of the junctions [21]. At variance, phosphory-
lation of occludin on serine/threonine involves casein kinase-2
[22,23] and atypical protein kinase C (aPKC). In particular, the
zeta isoform of aPKC was shown to interact with the coiled-coil
domain of occludin in the human intestinal T84 epithelial cells
[23,24]. As described in Section 3.1, aPKC is a key component of
the core polarity complex, thus suggesting that occludin
phosphorylation on serine/threonine favors TJ assembly.
If occludin phosphorylation facilitates TJ assembly, then one
can hypothesize the existence of control mechanisms that prevent
excessive phosphorylation. Actually, protein phosphatase 2A, a
holoenzyme with serine/threonine phosphatase activity, reduces
the phosphorylation levels of occludin (as well as ZO-1, claudin-1
and aPKC). The phosphatase has a negative effect on TJ integrity,
not only because stimuli that activate the phosphatase increase
paracellular permeability (that is, disrupt preformed TJ), but also
because expression of its catalytic subunit prevents the assembly
of TJ de novo. The physiological importance of the interaction
between the phosphatase and TJ proteins is reinforced by the
observation that, upon calcium-induced junction assembly, the
phosphatase is recruited to the cell membrane, where it can
interact with its TJ targets [25]. In addition to the protein kinases,
occludin interacts with lipid kinases. In particular, in human
intestinal Caco-2 epithelial cells, occludin associateswith p85, the
regulatory subunit of phosphatidyl-inositol 3-kinase (PI3K). As
the association of PI3K with occludin increases in response tooxidative stress, it may contribute to the PI3K-mediated
disassembly of the TJ that is observed in this condition [26].
Besides protein phosphatase 2A and PI3K, two additional
partners of occludin may contribute to TJ disassembly. First,
occludin binds (and regulates the junctional localization of) the
two subunits of the receptor for transforming growth factor-β
(TGF-β), which plays a major role in TJ disassembly, as detailed
in Section 3.7 [27]. Second, occludin binds the E3 ubiquitin-
ligase Itch. The interaction requires the amino terminus of
occludin and a multi-domain region of Itch, which encompasses
four WW motifs. Itch ubiquitinates occludin, thus leading to its
degradation in the proteasome [28]. Induced expression of Itch is
also the likely mechanism whereby dibutyryl-cAMP causes TJ
disassembly in Sertoli cells [29].
Finally, some TJ molecules (including occludin) interact with
diverse connexins, which are the membrane components of the
gap junctions. As the interactions between tight and gap
junctions are reviewed by Hervé et al. [30], here we will just
mention that occludin binds connexin-32. Using murine CHST8
hepatocytes transfected with human connexin-32, it was
reported that connexin-32 and occludin expression are co-
regulated [30]. The associations between tight (e.g., occludin,
ZO-1 and ZO-3) and gap junction (e.g., connexin-32, -43 and
-45) molecules suggest that connexins may assemble gap
junction channels in proximity of the TJ, thus coupling cell–
cell adhesion and communication.
2.2. Interactions of claudins
In addition to occludin and the recently described tricellulin
[31], also claudins were discovered as cell surface components of
the TJ [32]. Like occludin, also claudins associate with adapters
and enzymes. Concerning the adapters, claudins interact with the
ZO proteins. To test whether the interaction is PDZ-dependent,
the first, second and third PDZ domains (PDZ-1, -2 and -3,
respectively) of ZO-1 and ZO-2 have been recombinantly ex-
pressed (fused to a six-histidine tag) and used in binding assays
with the cytoplasmic domain of claudin-1 (fused to GST). Only
the PDZ-1 domains (of both ZO-1 and ZO-2) associate with
claudin-1. Interestingly, deletion of the Tyr-Val sequence from the
carboxyl terminus of claudin-1 abolishes the interaction with the
PDZ-1 domains. Using the same assay, it has been shown that the
PDZ-1 domain of ZO-1 directly binds the cytoplasmic tails of
claudin-1 to -8, which all share the Tyr-Val residues in their
carboxyl termini [33]. Another adapter that interacts with claudins
is multi-PDZ domain protein-1 (MUPP1), which is exclusively
concentrated at the epithelial TJ. MUPP1 contains thirteen PDZ
domains, and the tenth domain (PDZ-10) is responsible for the
interaction with the carboxyl terminus of claudin-1. Finally,
claudin-1 interacts with the adapter PATJ, which is a regulator of
cell polarity, as described in Section 3.4. The interaction is direct
and requires the eighth PDZ domain of PATJ and the carboxyl
terminus of claudin-1. Surprisingly, however, deleting the eight
PDZ domain has little effect on PATJ localization [34]. As
claudins are the building blocks of the TJ strands, all these
findings support a model, in which the PDZ-binding residues of
the claudins act as docking sites to attract PDZ-containing
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MUPP1 and PATJ [35]. It should be noted, however, that,
according to recent findings, ZO-1 and ZO-2 can determine the
site of claudin polymerization [36].
Concerning the enzymes, claudins interact with protein
kinases and matrix metalloproteinases. First, WNK4 is a kinase
that binds and phosphorylates claudin-1 in MDCK II cells.
Interestingly, gain-of-function mutations of WNK4, which
enhance the ability ofWNK4 to associate with and phosphorylate
claudin-1, are linked to a rare form of hereditary hypertension that
is characterized by increased chloride permeability [37]. Second,
claudin-1 directly interacts with the matrix metalloproteinases
MMP2 and MMP14, thus facilitating their recruitment to the
junctional area of the cell surface, which in turn increases the
MMP14-dependent activation of MMP2 [38].
2.3. Interactions of junctional adhesion molecules
Three members of the JAM family (JAM-A, -B and -C) share
significant sequence homology, including conserved PDZ-
binding motifs in the carboxyl terminus of their cytoplasmic
tails. JAM-A, which is the prototype of the family, interacts with
six adapters in a PDZ-dependent manner, as binding critically
requires its carboxyl terminal PDZ-binding motif Phe-Leu-Val.
First, JAM-A interacts with ZO-1. Full-length JAM-A (but not a
deletion mutant lacking the PDZ-binding motif) coprecipitates
with ZO-1 in the detergent-insoluble fraction of Caco-2 cells. In
addition, either a GST fusion protein containing the cytoplasmic
tail of JAM-A or a synthetic peptide corresponding to the
carboxyl terminal residues of JAM-A bind in vitro transcribed
and translated ZO-1 [39,40]. Second, JAM-A interacts with
MUPP1, in a way that requires the ninth PDZ domain of
MUPP1. Thus, MUPP1 is recruited to the epithelial TJ, by virtue
of its (mutually non-exclusive) associations with claudin-1 and
JAM-A (via the tenth and ninth PDZ domain, respectively) [35].
Third, JAM-A binds afadin, which is another PDZ domain-
containing protein associated with both the tight and the
adherens junctions. JAM-A lacking the PDZ-binding motif
does not co-distribute with afadin and localizes exclusively atFig. 2. Interactions between the members of the core polarity complex. The picture s
Par-6, Par-3 and aPKC. Arrow indicates the serine residues of Par-3 that are phosphor
slight increase and decrease of aPKC kinase activity upon interaction with Par-6 and Pcell borders [40]. Fourth, JAM-A interacts with CASK, which
(like the ZO proteins) belongs to the family of the membrane-
associated guanylate kinases (MAGUK). However, in addition
to the TJ, JAM-A and CASK also colocalize along the lateral
surface of the plasma membrane [41]. Fifth, JAM-A binds
protein interacting with protein C kinase-1 (PICK-1), a scaffold
molecule localized at both tight and adherens junctions in
epithelial cells. The interaction requires the PDZ domain of
PICK-1 [42]. Finally, JAM-A binds the polarity protein Par-3, as
discussed in Section 3.3 [43].
Although these findings suggest that these intracellular inter-
actions of JAM-A are instrumental (albeit to different degrees) in
recruiting JAM-A to the junctions, it should be noted that also its
extracellular and homophilic interactionsmight play a similar role
[44]. More in general, there are many examples of associations
between cell surface proteins. For instance, interactions between
claudins lead to the formation of polymers within the TJ strands
[45]. As alreadymentioned, the extracellular interactions between
the cell surface molecules may represent the molecular basis for
the barrier function of the TJ, which restricts and regulates
paracellular permeability [4].
3. The polarity system
TJ are closely associated with cell polarity. On one side, TJ
maintain the polarized subdivision of the plasma membrane into
the apical and basolateral domains. On the other side, some
polarity complexes determine the assembly and maintenance of
the TJ in their proper location at the boundary between the apical
and basolateral domains. The interplay between TJ and polarity
is the focus of recent reviews [2,46], as well as the accom-
panying articles by Le Bivic et al. and Cereijido et al. Here, we
concentrate on the molecular interactions within the polarity
cluster and subdivide the cluster into different groups of
interactions. First we describe a core complex that is linked to
the small GTPase Cdc42. Then, we examine the interactions of
the core complex with membrane proteins, regulatory mediators
and the actin cytoskeleton. Finally, we make a brief mention to a
group of interactions that links the core complex with thehows modular structure and molecular interactions of the core complex proteins
ylated upon interaction with aPKC. The plus/minus and minus symbols represent
ar-3, respectively. The interaction of Par-6 and aPKC with Cdc42 is also shown.
Fig. 3. Interactions within the polarity cluster. Part of the polarity cluster is
represented as a network of proteins linked by protein interactions (solid lines).
Thick lines highlight the interactions among the members of the core complex,
while the shape of the nodes represents the functional category of the individual
proteins.
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than the assembly) of the TJ.
3.1. The core complex
Together with aPKC, the two adapters Par-6 and Par-3 form a
highly conserved core complex within the polarity cluster.
Specifically, the three isoforms of Par-6 (Par-6A, -6B and -6C)
interact with Par-3 (which is also called ASIP). As shown in
Fig. 2, Par-6 contains a highly conserved region of about 125
residues, which in turn comprises a short sequence of twenty-two
residues and a PDZ domain. Part of the short sequence is called
semi-CRIB domain, because it matches the amino terminal half of
a consensus CRIB motif, an acronym for Cdc42 and Rac inter-
action binding. At variance, Par-3 contains three amino terminal
PDZ domains. The PDZ domain of Par-6 is necessary for binding
the amino terminus of Par-3. In particular, Par-6 binds the PDZ-1
domain (but not the PDZ-2 and -3 domains) of Par-3. In addition,
recombinant fragments containing only the PDZ domain of Par-6
and the PDZ-1 domain of Par-3 retain the ability to bind each
other, thus demonstrating that the interaction between Par-3 and
Par-6 is solely PDZ-dependent. Importantly, transfection of
MDCK cells with a construct corresponding to the amino
terminus of Par-3 (which interacts with Par-6) disrupts cell–cell
junctions with adjacent non-transfected cells. In contrast,
transfection of the carboxyl terminus of Par-3 (which does not
bind Par-6) has no effect, thus suggesting that the interaction
between Par-3 and Par-6 is important for the assembly and the
maintenance of the TJ [47,48].
Both Par-6 and Par-3 interact with the isoforms zeta and iota/
lambda of aPKC. Specifically, Par-6 interacts with aPKC via a
direct head-to-head association that involves the amino termini of
bothmolecules. Experiments with GST fusion fragments of Par-6
demonstrate that the amino terminus of Par-6 (between residues 1
and 100) is necessary and sufficient for the interactionwith aPKC.
However, the mutual effects of the interaction are rather limited.
On one side, no phosphorylation of Par-6 is detectable by kinase
assay after the interaction with aPKC. On the other side, Par-6
induces just a modest increase in the kinase activity of aPKC [49].
At variance, the interaction of Par-3 with aPKC requires the
carboxyl terminal region of Par-3 and the catalytic domain of
aPKC. The aPKC-binding region of Par-3 includes two highly
conserved residues (Ser827 and Ser829) that are phosphorylated
by aPKC. In addition, the interaction of aPKCwith Par-3 reduces
the kinase activity of aPKC, thus suggesting that Par-3 holds
aPKC in an inactive conformation. Importantly, aPKC colocalizes
with Par-3 at the TJ of epithelial cells. Also, overexpression of
Par-3 (but not a Par-3 deletion mutant lacking the aPKC-binding
domain) accelerates TJ formation inMDCKcells, thus suggesting
that also the interaction between Par-3 and aPKC favors the
assembly of the TJ [50].
3.2. Interactions of the core complex with small G proteins
The core complex is linked to the general polarity system by
virtue of its associations with Cdc42 (Fig. 3). In particular, both
Par-6 and aPKC interact with Cdc42, while the exchange factorEct-2 contributes additional linkages between these proteins.
Specifically, the three isoforms of Par-6 associate with Cdc42 in
its active (i.e., GTP-bound) state, as detected in binding assays
[49]. The partial CRIB sequence of Par-6 is required for the
interaction with active Cdc42. However, the critical residues that
mediate the interaction are different from those found in classical
CRIB domains. Actually, mutations of residues that are conserved
in theCRIBdomains (i.e., Ile133, Ser134, Pro136 and Phe139) do
not abrogate the binding of Cdc42 to Par-6B. Thus, the interaction
between GTP-bound Cdc42 and Par6 probably involves novel
protein–protein recognition motifs [47]. In addition, also aPKC
associates with GTP-bound Cdc42, via the regulatory domain of
aPKC. Expression of activated Cdc42 results in the translocation
of aPKC lambda from the nucleus to the cytosol, so that Cdc42
may then colocalize with aPKC at the plasma membrane. An
additional effect of expressing activated Cdc42 is the loss of stress
fibers, as does overexpression of either wild-type or activated
aPKC [51].
Activation of Cdc42 requires the guanine nucleotide exchange
factor Ect-2. However, besides activating Cdc42, Ect-2 also
interacts with Par-6 and aPKC with important functional
consequences. Actually, when co-expressed with Ect-2, Par-6
enhances the activity of both Ect-2 (with resulting accumulation
of GTP-bound Cdc42) and aPKC. Also, overexpression of Par-6
alone stimulates Cdc42 and aPKC activity, albeit to a lesser extent
than the co-expression of Par-6 and Ect-2. Thus, Ect-2, Par-6 and
aPKC form another tripartite complex, which interacts physically
and functionally with the core complex [52]. Finally, it is
noteworthy that, in addition to Cdc42, the core complex interacts
with other small GTPases. First, the three isoforms of Par-6
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motif [49]. Second, Par-3 interacts indirectly with RhoA, as
discussed in Section 3.6.
3.3. Interactions of the core complex with membrane proteins
During junction assembly, the core complex contributes to
restricting the localization of Cdc42-dependent polarity stimuli to
a well-defined region of the plasma membrane (i.e., the
prospective junctional area) by virtue of associations with integral
membrane proteins. These proteins belong to two immunoglo-
bulin-like families of adhesionmolecules, i.e., the JAM family (at
the TJ) and the nectin family (at the adherens junctions). In
particular, as mentioned in Section 2.3, JAM-A associates with
Par-3. The interaction requires the carboxyl terminal PDZ-
binding residues of JAM-A and the first PDZ domain of Par-3.
The PDZ-dependent interaction of Par-3 with JAM-A is specific,
as the interaction of Par-3 with occludin is very weak, while no
interaction with claudins is detectable [43,53]. Thus, JAM-Amay
be regarded to as amembrane protein that acts as a docking site for
the core complex, which is an essential step for the establishment
of polarity and the formation of the TJ.
3.4. The core complex interacts with apical and basolateral
polarity complexes
To coordinate membrane polarization in a more efficient
manner, the core complex interacts with two conserved com-
plexes that are localized to the apical and basolateral domains.
The apical complex comprises homologs of the Drosophila
Crumbs, Stardust and Inadl. The basolateral complex comprises
homologs of the Drosophila Lethal Giant larvae, Discs lost and
Discs large (Fig. 3).
Crumbs-3 is the human homolog of Drosophila Crumbs,
which is an apical transmembrane protein crucial for epithelial
morphogenesis in the fly embryo. In humans, Crumbs-3 is
expressed in epithelial tissues and skeletal muscles. In addition, in
intestinal epithelial cells, Crumbs-3 is localized to apical and sub-
apical areas, which suggests that it may regulate polarity in
humans as well. InMDCK cells, Crumbs-3 interacts directly with
Par-6. The interaction requires the four last amino acids (Glu-Arg-
Leu-Ile) of Crumbs-3 [54]. Furthermore, Crumbs-3 promotes the
recruitment of Par-6 to the plasma membrane also indirectly, via
the adapter PALS1 (or MPP5), which is the mammalian homolog
of Drosophila Stardust. In MDCK cells, the interaction requires
the amino terminus of PALS1 and the PDZ domain of Par-6 and is
regulated by Cdc42-GTP [55]. Finally, besides interacting with
Crumbs-3 and Par-6, PALS1 also interacts with the multi-PDZ
domain protein PATJ, the mammalian homolog of Drosophila
Inadl. The interaction requires a direct association between the
L27N domain of PALS1 and theMAGUK-recruitment domain of
PATJ [55]. Finally, to further stress the importance of the link
between the apical complex and the TJ, it should also be
mentioned that the carboxyl terminal residues of both ZO-3 (Thr-
Asp-Leu) and claudin-1 (Tyr-Val) interact directly with the sixth
and eighth PDZ domain of PATJ, respectively. Interestingly, a
PATJ deletion mutant missing the sixth (but not the eighth) PDZdomain is localized away from the TJ, thus suggesting that the
interaction with ZO-3 is important for the recruitment of PATJ
(and its associated proteins) to the TJ [34].
Concerning the basolateral complex, the connections with the
core complex are mediated by direct interactions of both aPKC
and Par-6 with Lethal Giant larvae-1 (LLGL1). The PDZ domain
of Par-6 binds directly the amino terminus of LLGL1 (which
contains a WD40 interaction domain), whereas the association of
the amino terminus of Par-6 with LLGL1 (observed in vitro) is
probably indirect andmediated by aPKC. Furthermore, LLGL1 is
a substrate for aPKC and contains five highly conserved and
closely spaced serine residues that correspond to a consensus site
for aPKC phosphorylation. Although the stable interaction of
LLGL1with aPKC is independent on these phosphorylation sites,
the aPKC-dependent phosphorylation of LLGL1 is functionally
important, because expression of a LLGL1 mutant lacking the
five serine residues reduces cell polarization in response to cell
wounding [56]. Finally, LLGL1 also interacts with myosin, thus
providing a link between the polarity and cytoskeletal clusters
[57].
3.5. Interactions of the core complex with signaling molecules
Signaling proteins, which are homologs of molecules that
control polarization in the Caenorhabditis elegans embryo, also
regulate the core polarity complex in mammalian epithelial
cells (Fig. 3). Mark-2, which is the mammalian homolog of
C. elegans PAR-1, binds and phosphorylates Par-3. Most of the
effects of PAR-1-like molecules (including Mark-2) are
mediated by the interaction of their phosphorylated substrates
with 14-3-3 proteins. Actually, the Mark-2-induced phosphor-
ylation of Par-3 (on two conserved serine residues) generates
binding sites for the zeta isoform of protein 14-3-3, which is the
mammalian homolog of C. elegans PAR-5 [58]. Thus, in
epithelial cells, 14-3-3 binds Par-3 in a phosphorylation-
dependent manner. The binding of 14-3-3 to Par-3 inhibits the
formation of the core complex, by blocking both the self-
association of Par-3 and the association of Par-3with aPKC [59].
AsMark-2 exerts a negative effect on the assembly of the core
complex, two control mechanisms limit the consequences of the
Mark-2-dependent phosphorylation of Par-3. First, aPKC phos-
phorylates Mark-2, thus reducing both the kinase activity of
Mark-2 and its localization to the plasmamembrane [60]. Second,
the aPKC-dependent phosphorylation of Mark-2 enhances the
binding of 14-3-3 to Mark-2, which possibly leads to the
dissociation of Mark-2 from the lateral membrane, thus again
limiting its effects as inhibitor of polarity [61]. Lastly, as
mentioned in Section 2.1, protein phosphatase 2A critically
regulates activity and distribution of aPKC during TJ formation,
thus providing an additional example whereby signaling path-
ways regulate the formation of the core complex [25].
3.6. Interactions of the core complex with actin regulators
Two sets of interactions provide a link between the polarity
system and the actin-based cytoskeleton. First, Par-3 binds and
inhibits the kinase LIMK-2. The interaction requires the
Fig. 4. Interactions within the adapter/cytoskeleton cluster. Part of the adapter/
cytoskeleton cluster is represented as a network of protein interactions. Thick
lines highlight the direct interactions of the ZO proteins with each other and with
actin.
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turn, LIMK-2 phosphorylates cofilin on Ser3 [62], thereby
inhibiting the cofilin-dependent reorganization of actin [63].
Thus, by inhibiting LIMK-2, Par-3 relieves the inhibition of
cofilin, thereby facilitating actin dynamics during cell polari-
zation and TJ formation. Second, the carboxyl terminal region
of Par-3 also binds the Rac exchange factor Tiam-1 [64]. In turn,
Tiam-1 binds and activates Rac-1 [65]. The observation that the
knockdown of Tiam-1 enhances TJ formation in cells lacking
Par-3 suggests that, under normal conditions, Par-3 enables
polarity establishment and TJ assembly by reducing Tiam-1
activity (and consequently Rac-1 activation).
3.7. Protein interactions in the disassembly of the TJ
Most of the interactions described in this section regulate TJ
assembly during the establishment of cell polarity. At variance, an
additional group of interactions regulates TJ disassembly, which
may occur under both physiologic and pathologic conditions
(e.g., the epithelial-to-mesenchymal transition in tumor cells).
The pathway is regulated in response to TGF-β. Briefly, binding
of TGF-β to its membrane receptor leads to RhoA degradation by
activating a pathway that comprises the TGF-R1 and TGF-R2
subunits of the receptor, Par-6 and the E3 ubiquitin ligase Smurf-
1. More specifically, in the absence of TGF-β, TGF-R1 and Par-6
form a complex at the TJ via the amino terminus of Par-6.
However, in the presence of TGF-β, the TGF-β-induced
assembly of the TGF-R1/TGF-R2 heterodimer brings TGF-R2
in proximity of Par-6 (bound to TGF-R1). In this way, TGF-R2
phosphorylates Par-6 on Ser345. Then, phosphorylated Par-6
interacts with Smurf-1, and in turn Smurf-1 ubiquitinates RhoA,
thus leading to RhoA degradation in the proteasome and to TJ
destabilization [66]. Finally, it should be mentioned that Smurf-1
also interacts with aPKC, even though the association is likely
more important for the formation of cell protrusions in the context
of polarized migration rather than for TJ disassembly [67].
4. Adapters and the cytoskeleton
TJ stabilization requires several interactions with the actin
cytoskeleton. In particular, some adapters serve the specific
purpose of linking the cell surfacemolecules (described in Section
2) with the actin filaments. We subdivide this cluster of inter-
actions into three groups. We first describe the interactions of the
three adapters ZO-1, -2 and -3 and then the interactions of two
other adapters, namely cingulin and afadin. Finally, emerging
evidence indicates that cell adhesion profoundly affects gene
expression and cell proliferation. Thus, the adapters of the TJmay
exert functions that go well beyond their structural role.
Therefore, at the end of this section, we will make a brief
mention to the interactions of ZO-1 and -2 with transcription
factors and regulators of the cell cycle.
4.1. Interactions of the zonula occludens proteins
A central core of interactions within the adapter/cytoskeleton
cluster is centered on the zonula occludens proteins ZO-1, ZO-2and ZO-3. As represented schematically in Fig. 4, the ZO proteins
interact with each other, as well as with actin and actin-associated
proteins. Concerning the mutual interactions, it has been shown
that ZO-1 binds both ZO-2 and ZO-3, but that ZO-2 and ZO-3 do
not bind each other. Immunoprecipitation of protein constructs
from transfected MDCK cells indicates that ZO-1 interacts with
ZO-2 in the cell, and that the interaction requires the second PDZ
domain (PDZ-2) of each interacting protein [19]. Similarly, ZO-1
interacts directly with ZO-3. Specifically, recombinant ZO-3
binds in vitro transcribed and translated ZO-1 (but not ZO-2), as
detected by in vitro binding assay, and the interaction requires the
amino terminal half of ZO-3. In addition, ZO-1 colocalizes with
both ZO-2 and ZO-3 at the TJ of MDCK cells. Finally, in spite of
the ability of ZO-1 and ZO-2 to bind each other, the presence of
ZO-1 bound to a ZO-3 affinity column does not result in the
retention of ZO-2, thus indicating that ZO-1 does not bridge ZO-2
with ZO-3 and that ZO-1 forms two distinct ZO-1/ZO-2 and ZO-
1/ZO-3 complexes [16].
Concerning the interactions with the actin cytoskeleton, the
three ZO proteins interact with actin either directly or indirectly
via actin-associated proteins (including the adapters cingulin and
afadin that are described in Section 4.2). The direct interaction of
ZO-1 with actin requires the 220-amino acid long (and proline-
rich) actin-binding region of ZO-1, as shown in pull-down
assays from lysates of MDCK cells. Interestingly, the actin-
binding region is required for the localization of ZO-1 not only to
the junctions of contacting cells but also to the free edge of non-
contacting cells before junction assembly. In the latter condition,
the actin-rich pool of ZO-1 appears clustered with a punctuate
pattern. Thus, the interaction between ZO-1 and F-actin likely
plays different roles during the different steps of TJ assembly
[68]. Finally, like ZO-1, also ZO-2 and ZO-3 colocalize with
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F-actin, as shown by in vitro binding and actin co-sedimentation
assays [19].
The indirect interaction between ZO-1 and actin involves
cortactin and α-catenin, as well as cingulin and afadin. The inter-
action between the Drosophila homologs of cortactin and ZO-1
requires the SH3 domain of cortactin and the Pro-X-X-Pro motif
in the proline-rich domain of ZO-1. In turn, the interaction of
cortactin with actin requires the fourth of six tandem repeats and
the amino terminal acidic region of cortactin. By virtue of these
interactions, cortactin contributes to coupling the spatial organi-
zation of actin with junction assembly [69]. The indirect inter-
action of ZO-1with actin also involvesα-catenin, even though the
latter is a component of the adherens junctions. Actually, in non-
epithelial cells, ZO-1 interacts directly with α-catenin and actin,
in a way that involves the amino and carboxyl terminal halves of
ZO-1, respectively. In this way, ZO-1 links the cadherin/catenin
complexwith the actin cytoskeleton, at least in non-epithelial cells
[70]. Interestingly, the structural requirements for the interaction
of α-catenin with actin are similar (but not identical) to those of
vinculin. In particular, although α-catenin shares sequence simi-
larity with vinculin, α-catenin contains an additional stretch of
forty-two residues that is carboxyl terminal with respect to the
region of homology with vinculin. Deletion of these residues
impairs the binding to actin (without affecting protein folding),
thus suggesting that they may mediate the binding of α-catenin to
actin [71].
The indirect interaction of ZO-2with actin involvesα-catenin
and protein 4.1. Like ZO-1, also ZO-2 binds α-catenin directly
via the amino terminal domain of ZO-2 [15]. At variance, protein
4.1R (the prototype of the protein 4.1 family) maintains the
mechanical integrity of the membranes by binding cooperatively
spectrin and actin (via a spectrin- and actin-binding domain).
Two 4.1R isoforms of 135 and 150 kDa interact with ZO-2. The
interaction requires the region encoded by exons 19–21 of 4.1R
and the region between residues 1054 and 1118 of ZO-2 [72]. In
addition, protein 4.1R colocalizes with ZO-2 at the TJ of MDCK
cells. In turn, protein 4.1 interacts with actin via a eight residue
motif (Leu-Lys-Lys-Asn-Phe-Met-Glu-Ser) within the spectrin-
and actin-binding domain [73].
4.2. Interactions of cingulin and afadin
Cingulin is an intracellular component of the epithelial TJ. As
cingulin contains distinct domains responsible for the interaction
with other proteins, it represents an additional adapter that links
the TJ to the cytoskeleton (Fig. 4). Specifically, besides binding
actin and myosin, cingulin interacts with the ZO proteins and
afadin. In particular, a conserved ZO-1 interaction motif
encompassing residues 48–61 at the amino terminus of cingulin
is required for the interaction of cingulin with ZO-1 in vitro.
Also, the observation that the overexpression of Xenopus
cingulin in the A6 epithelial cells affects the localization of
endogenous ZO-1 further indicates that the interaction between
cingulin and ZO-1 is functionally important [74]. In addition,
like ZO-1, also ZO-2 immunoprecipitates of MDCK cells
contain cingulin. Similarly, like ZO-1, also ZO-2 and ZO-3interact in vitro with the amino terminal fragment of cingulin.
However, the amino terminal fragment alone is not targeted to
the TJ. Thus, sequences in the head region of cingulin are
essential for targeting cingulin to the TJ (most likely because of
the interactions with the ZO proteins), but not sufficient, and
additional sequences in the rod region are important as well [75].
The interaction of cingulin with F-actin has been studied in
vitro. Purified full-length cingulin co-sediments with F-actin
under high-speed centrifugation and promotes sedimentation of
F-actin under low-speed centrifugation, thus suggesting that
cingulin is an actin cross-linking protein [76]. Cingulin, however,
interacts not only with actin but also with myosin. The interaction
with myosin may transduce the mechanical force (that is gene-
rated by the contraction of the peri-junctional actomyosin ring) to
the TJ proteins, thus contributing to the regulation of paracellular
permeability. Both the amino and the carboxyl terminal fragments
of cingulin mediate the interaction with myosin in vitro [75].
Furthermore, cingulin also interacts with afadin, in a way that
requires the amino terminal fragment of cingulin [75]. Finally,
cingulin also interacts (and colocalizes at the junctions) with the
oncoprotein GEF-H1. GEF-H1 is a guanine nucleotide exchange
factor that activates RhoA [77]. The interaction between GEF-H1
and cingulin, which requires the Pleckstrin-homology domain of
GEF-H1 and the rod domain of cingulin, results in the inhibition
of GEF-H1, thus providing a molecular mechanism whereby TJ
formation results in RhoA inactivation [78].
Besides associating with cingulin, afadin associates with ZO-1
[79] and ZO-3 [80]. Specifically, ZO-1 interacts with the Ras-
binding domain of afadin, in a way that is inhibited by activated
Ras. In cells lacking TJ, afadin accumulates with ZO-1 at the
adherens junctions [79]. In addition, afadin binds α-catenin and
nectin, thus contributing to the localization of the complex be-
tween nectin, afadin and ponsin in proximity of the adherens
junctions. The afadin-binding site has been mapped to the 385–
651 fragment of α-catenin, which contains two adjacent bundles
of four helices. Interestingly, the relative orientation of the two
bundles may switch from about 40° to approximately 90°, which
likely correspond to closed and open conformations with reduced
and enhanced ability to bind afadin, respectively [71]. Lastly,
afadin binds Ras. Actually, afadin was discovered as a Ras-
binding protein and partially purified by chromatography on a
GST-Ras affinity column [81]. In turn, as it is well known, Ras
interacts with Raf-1, thus establishing a link between junctions
and the Ras signaling pathway [82].
4.3. Interactions of ZO-1 and ZO-2 with transcription factors
and cell cycle regulators
As the interactions of ZO-1 andZO-2with transcription factors
and regulators of the cell cycle have been reviewed in detail [83],
here we will briefly summarize molecular determinants and
functional significance of such interactions. Specifically, ZO-1
binds (via its SH3 domain) the Y-box transcription factor ZO-1-
associated nucleic acid binding (ZONAB). As a consequence of
their interaction, ZONAB and ZO-1 together regulate the pro-
moter of erbB-2, which is a tyrosine kinase co-receptor important
for epithelial differentiation. Interestingly, ZO-1 regulates
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transcription factor. Specifically, in non-confluent cells, ZONAB
is free to accumulate in the nucleus and to act as a repressor of the
erbB-2 gene. At variance, in confluent cells, ZONAB is seques-
tered at the TJ (because of its association with ZO-1) and can no
longer act as a repressor in the nucleus. Thus, the discovery of the
ZONAB-dependent regulation of erbB-2 expression has unveiled
a mechanism whereby TJ modulate the expression of epithelial-
specific differentiation genes [84]. In addition to ZO-1, ZONAB
also associates with cell division kinase-4. Importantly, reduction
of the nuclear levels of ZONAB (e.g., in confluent cells) results in
reduced nuclear levels of cell division kinase-4 too. Thus, by
sequestering ZONAB at the TJ, ZO-1 also prevents the nuclear
accumulation of cell division kinase-4. In this way, TJ not only
favor epithelial differentiation, but also reduce cell proliferation in
a cell density-dependent manner [85]. Along the same line,
ZONAB also interacts with RalA in a GTP-dependentmanner. As
the levels of the RalA-ZONAB complex increase as epithelial
cells become dense, also the interaction of ZONAB with RalA
(like the interaction of ZONAB with ZO-1) may relieve the
transcriptional repression of ZONAB [86]. Finally, ZO-1 interacts
with the heat-shock protein Apg-2. In particular, Apg-2 copre-
cipitates with ZO-1 and partially localizes to the intercellular
junctions of MDKC cells. As Apg-2 competes with ZONAB for
binding the SH3 domain of ZO-1, Apg-2 may favor the repressor
activity of ZONAB [87].
Like ZO-1, also ZO-2 interacts with transcription factors and
regulators of the cell cycle. However, at variance with ZO-1, a
pool of ZO-2 localizes to the nucleus (at least in non-contacting
cells). As the nuclear localization suggests that ZO-2 itself
might directly regulate gene expression, the interaction of ZO-2
(expressed as GST-fusion protein) with different transcription
factors has been studied in detail. These studies have reported that
ZO-2 interacts with Jun, Fos and CEBPG and that the interactions
require the carboxyl terminal region of ZO-2. Surprisingly,
however, the interactions do not occur only at the nucleus but also
at the TJ. The association of ZO-2 with Jun/Fos at the TJ might
sequester the Jun/Fos complex at the plasma membrane and thus
lower its levels in the nucleus. As a net result, junctional ZO-2
might indirectly affect the activity of the Jun/Fos complex in
the regulation of gene transcription. Although transfected ZO-2
down-regulates the expression levels of such factors, it does not
affect aspecifically the global levels of gene transcription [88].
Furthermore, nuclear ZO-2 also interacts with the DNA-binding
protein scaffold attachment factor-B, as shown by coprecipitation
assays [89].
Finally, ZO-1 and ZO-2 interact with the p120-like catenin
ARVC. Both interactions require the carboxyl terminal PDZ-
binding motif of ARVC and the PDZ domains of ZO-1 and ZO-2.
However, there are interesting differences between ZO-1 and ZO-
2. On one side, ARVC and ZO-1 partially colocalize in the
vicinity of the apical adhesion complex. In addition, ARVC, ZO-1
and E-cadherin are recruited as a complex to the sites of initial
cell–cell contact. On the other side, ARVC colocalizes with ZO-2
in the nucleus. Thus, the selective interaction with either ZO-1 or
ZO-2 may mediate the recruitment of ARVC to either the plasma
membrane or the nucleus [90].4.4. Other interactions of the ZO proteins
The ZO proteins interact with other signaling molecules and
with some connexins. Specifically, the SH3 domain of ZO-1
binds the serine/threonine kinase ZAK, which appears to be
associated with junctional complexes in MDCK cells. In turn,
ZAK phosphorylates a region of ZO-1 that is carboxyl terminal
with respect to the SH3 domain [91]. Furthermore, ZO-3 binds
the p120 catenin, which (besides being a component of the
adherens junctions) is implicated in the regulation of the
cytoskeleton and cell motility. Notably, altered interactions
between ZO-3 and p120 in cells expressing the amino-terminal
half of ZO-3 affect RhoA activity, thus establishing a further
link between the TJ and RhoA signaling [80].
Concerning the connexins, ZO-1 was shown to interact with
connexin-43. The interaction requires the carboxyl terminus of
connexin-43 and the second PDZ domain of ZO-1. Connexin-43
and ZO-1 colocalize at the gap junctions of transfected COS-7
cells, thus suggesting that ZO-1 is involved in the clustering and
assembly of connexin-43-based gap junctional channels [92]. In
addition, both ZO-1 and ZO-3 interact and colocalize with
connexin-45. Again, the interactions require the PDZ domains of
the ZO proteins and the carboxyl terminus of connexin-45.
Mutation of the carboxyl terminal residues (Ser-Val-Trp-Ile) of
connexin-45 abolishes the interactions with ZO-1 and ZO-3 [93].
5. Other adapters and signaling systems
An additional cluster of protein interactions is centered on a
class of adapters named membrane-associated guanylate kinase
with inverted orientation (MAGI). These interactions serve
different functions. First, like the ZO proteins, they act as
scaffolds that link cell surface molecules with the actin cyto-
skeleton. Second, they modulate cell signaling. Third, they inter-
act with a system that regulates the recycling of the junctional cell
surface molecules.
5.1. Interactions of MAGI-1 with cell surface molecules and the
actin cytoskeleton
MAGI-1 is a membrane-associated protein expressed at the
TJ, which encompasses a guanylate kinase domain, two WW
domains and six PDZ domains. Like other PDZ proteins, also the
PDZ domains of MAGI-1 interact with the carboxyl termini of
other proteins, including three cell surface (and immunoglo-
bulin-like) molecules (i.e., JAM-4, ESAM-1 and CXAR) and an
actin-binding protein (i.e., α-actinin-4), as described below.
Like JAM-A, also JAM-4 belongs to the JAM family. The
interaction between JAM-4 and MAGI-1 requires the carboxyl
terminus of JAM-4 and two PDZ domains (the first and fourth)
of MAGI-1. It is likely that the interaction provides the TJ with
an additional adhesion system, which may regulate permeability
in kidney glomeruli and the small intestine. Interestingly, JAM-4
does not bind ZO-1, whereas JAM-A does not bind MAGI-1
[94]. The biochemical basis of this specificity has been defined
in detail. The carboxyl termini of PDZ-binding proteins are
divided into two classes depending on whether they harbor a
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PDZ domains (like the domains of MAGI-1) contain a critical
histidine residue in the second α-helix and bind proteins ending
with the consensus motif Ser/Thr-X-ΦCOOH (X, any residue;Φ,
hydrophobic residue). At variance, type II PDZ domains (like
the domains of ZO-1) contain a hydrophobic residue in the
second α-helix and bind proteins ending with the consensus
motif Phe/Tyr-X-ΦCOOH [95]. Thus, JAM-A,which ends in Phe-
Leu-Val, binds ZO-1 (precisely, the type II PDZ-2 and PDZ-3
domains) [39,40], but not MAGI-1. In contrast, JAM-4, which
ends in Thr-Leu-Val, bindsMAGI-1 (precisely, the type I PDZ-1
and PDZ-4 domains), but not ZO-1 [94].
Endothelial cell-selective adhesion molecule-1 is another cell
surface protein associated with the TJ. As the carboxyl tail of
ESAM-1 ends with a consensus motif (Thr-Leu-Leu) for binding
type I PDZ domains, it may anchorMAGI-1 to the endothelial TJ.
Binding studies using a MAGI-1 fragment (which encompasses
residues 789–876 and contains the PDZ-3 domain) further
suggest that the interaction is PDZ-dependent [96]. In addition,
the third cell surface molecule that binds MAGI-1 is Coxsackie
and Adenovirus Receptor. This molecule plays a role not only in
forming epithelial junctions, but also in modulating cell growth
and, as the name indicates, in facilitating viral infection. Its
carboxyl terminus, which ends with a consensus motif (Ser-Ile-
Val) for binding type I PDZ domains, plays a role in cellular
localization, cell–cell adhesion and cell growth, as well as in the
interaction with MAGI-1. In addition to MAGI-1, the Coxsackie
and Adenovirus Receptor also interacts with PICK-1, another
PDZ protein which contains a single PDZ domain and forms
homodimers [97].
As mentioned above, also MAGI proteins may link the cell
surface molecules of the TJ with the actin cytoskeleton. Limited
information, however, is available concerning the molecules
involved. MAGI-1 binds actinin-4, the non-muscle isoform of the
actin-binding protein α-actinin. The interaction requires the fifth
PDZ domain of MAGI-1 and the cytoplasmic tail of actinin-4,
whose carboxyl terminus ends with a consensus motif (Ser-Asp-
Leu) for binding type I PDZ domains [98]. Interestingly, the
expression levels of actinin-4 are increased at the edge of cells that
migrate into a wound. In addition, it shuttles between cytoplasm
and nucleus, thus suggesting that actinin-4 (possibly in
association withMAGI-1) may regulate actin dynamics [99,100].
5.2. Interactions of MAGI proteins with signaling molecules
The three members of the MAGI family (MAGI-1, -2 and -3)
also interact with the lipid phosphatase PTEN. As PTEN
contains the carboxyl terminal PDZ-binding residues Thr-Lys-
Val, also the interactions of PTEN with the MAGI proteins are
likely PDZ-dependent. In general, the binding of the MAGI
proteins to PTEN enhances the enzymatic activity of PTEN.
Actually, PTEN converts the phosphatidyl-inositol PIP3 back to
PIP2. In this way, PTEN counteracts the effect of PI3K (which
catalyzes the production of PIP3) and indirectly inactivates the
effectors of PIP3, including protein kinase Akt. Thus, MAGI
proteins link the TJ with a major pathway that regulates growth
and survival in normal cells. PTEN, however, is also a tumorsuppressor. Some mutations in tumors (for instance, in glio-
blastoma and endometrial tumors) affect the carboxyl terminus
of PTEN. In particular, mutations that either insert a premature
stop codon or add residues after the stop codon alter the PDZ-
binding motif and predictably abolish the interactions of PTEN
with its PDZ partners, including theMAGI proteins. If the loss of
such interactions results in reduced PTEN activity (and thus in
enhanced Akt activity), then this cluster of junctional interac-
tions may acquire relevance to neoplastic transformation as well.
In this respect, it is noteworthy that the MAGI proteins are
targets for viral oncoproteins.
More specifically, the isoform MAGI-1b interacts directly
with PTEN via the carboxyl terminus of PTEN and the second
PDZ domain of MAGI-1b [101]. Similarly, MAGI-2 localizes to
the epithelial TJ and binds the carboxyl terminus of PTEN via
the second PDZ domain. Expression of MAGI-2 reduces Akt
activation, thus indicating that also MAGI-2 favors the activity
of PTEN. Conversely, PTEN mutants that fail to bind MAGI-2
are impaired in their ability to prevent Akt activation.
Nevertheless, these mutants only exert a partial effect, thus
suggesting that these adapters merely optimize the activity of the
associated enzyme [102]. In addition, also MAGI-3 localizes to
the epithelial TJ and binds PTEN. Again, PTEN depho-
sphorylates PIP3 more efficiently when it is associated with
MAGI-3 [102]. Finally, in addition to PTEN, MAGI-3 interacts
with another phosphatase, the receptor tyrosine phosphatase
PTPRB, which is involved in the control of cell–cell and cell–
matrix adhesion. The interaction of PTPRB with MAGI-3
requires the carboxyl terminus of PTPRB and the third or fourth
PDZ domain of MAGI-3. In this way,MAGI-3 may link PTPRB
with its substrates at the plasma membrane [103]. Lastly, outside
the TJ, PTEN interacts indirectly with β-catenin by binding
MAGI-1b. In this way, PTEN is also recruited to the adherens
junctions. As β-catenin also binds PI3K, the adherens junctions
may thus function as a central point for regulating the PIP3 pool
and its effectors. Thus, although devoid of enzymatic activity,
MAGI proteins likely play a general role in organizing signaling
complexes that control cell growth and differentiation [101].
5.3. Interactions of MAGI-1 with a system for the recycling of
junctional proteins
Like other membrane proteins, also the cell surface
components of the TJ undergo constitutive recycling from the
membrane to the early endosomes and back to the membrane. It
appears that the activation state of Cdc42 is critical for deter-
mining the fate of the endocytosed proteins. In particular, when
Cdc-42 is inactive (i.e., GDP-bound), the endocytosed mole-
cules remain in the early endosomes and are recycled to the
membrane. In contrast, when Cdc42 is active (i.e., GTP-bound),
the endocytosed molecules are transferred to the late endosomes
and targeted to lysosomes for degradation. The molecule that
negatively regulates the activation state of Cdc42 in the
endosomes (and thus the fate of the endocytosed junctional
molecules) is Rich-1, a GTPase-activating protein (GAP) for
Cdc42 [104]. The importance of Rich-1 for TJ integrity is
supported by the observation that silencing Rich-1 expression
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Rich-1 induces a similar phenotype, thus stressing that the TJ-
stabilizing effect of Rich-1 is attributable to the inactivation of
Cdc42 [104].
Rich-1 comes in close contact with the TJ by virtue of its
association with the scaffolding protein angiomotin. The BAR/
coiled-coil regions of Rich-1 and angiomotin are necessary for
such heterotypic binding. The BAR (an acronym for Bin/
Amphiphysin/Rvs) domain is a widely conserved interaction
domain [105]. In turn, angiomotin associates with three junctional
proteins, MAGI-1, PATJ and MUPP1. First, the p130 isoform of
angiomotin binds MAGI-1b. The interaction requires the amino
terminal motif Pro-Pro-X-Tyr of angiomotin and theWWdomain
of MAGI-1 [106]. Second, angiomotin interacts with PATJ. The
PDZ-binding motif at the carboxyl terminus of angiomotin (Asp-
Tyr-Leu-Ile) binds PATJ. Third, it has been recently discovered
that angiomotin also interacts withMUPP1. The interaction again
requires the PDZ-binding motif of angiomotin and the PDZ-2 and
-3 domains of MUPP1. Surprisingly, however, the absence of the
PDZ-binding motif does not alter the subcellular distribution of
angiomotin. Thus, it is likely that PATJ and MUPP1 may have
redundant roles (with respect to MAGI-1) in determining the
localization of angiomotin to the TJ [107]. Finally, it is worth
mentioning that CD2AP and SH3K1 are two molecules that
associate with Rich-1. CD2AP and SH3K1 bind each other
directly and target cell surface molecules (e.g., growth factor
receptors) for endocytosis. The ability of angiomotin to recruit
Rich-1 may thus impact on the trafficking of TJ components via
the association of Rich-1 with CD2AP and SH3K1.
6. Concluding remarks
The TJ exert two major functions, which are traditionally
designated as ‘barrier’ and ‘fence’. While the term barrier refers
to the control of paracellular permeability across lateral
intercellular spaces, the term fence describes the emergence
and maintenance of apico-basal polarity within the plasma
membrane. Predictably, the individual features of the TJ
molecules and their mutual interactions (that have been outlined
in this review) represent the molecular basis for a mechanistic
explanation of these complex functions.
Although our understanding is far from being complete, we
have attempted here at drawing correlations between the different
clusters of protein interactions and their possible role in TJ
function. In general, the interactions that involve the adhesive
surface molecules of the TJ (as described in Section 2) are
primarily instrumental in building the paracellular barrier, as they
seal the lateral intercellular spaces between adjacent cells. At
variance, the interactions that involve the evolutionary conserved
polarity complexes (as described in Section 3) are instrumental in
setting up the polarity fence, as they determine the correct
localization of the TJ at the apico-basal boundary and the ability of
the TJ to maintain such polarization of the membrane. In addition
to these two major protein clusters, emerging evidence indicates
that, like other junctional systems of the cells (e.g., adherens
junctions, desmosomes and focal adhesions), the actin-based
cytoskeleton (as described in Section 4) plays a key role inreinforcing the adhesive complexes of the barrier and in
translating polarity determinants of the fence into spatially
defined responses. Finally, far from being a static system, the
TJ undergo dynamic changes in response to various signaling
pathways (as described in Section 5 and throughout the text).
Once the complete map of protein interactions will be avail-
able, we can expect to gain deeper understanding of TJ in all the
steps of their lifespan, from the assembly (in response to
coordinated polarity cues), to the stabilization (via dynamic
linkages to adapter and cytoskeletal proteins), to the maintenance
(via regulated membrane trafficking) and finally to the disassem-
bly (for instance, via ubiquitination events). An additional major
challenge will consist in defining how the molecular interactions
among the TJ components translate stimuli from signaling
mediators (for instance, phosphorylation events) into functional
responses. In the end, when the TJ cartography will be complete,
we foresee that the TJ, no matter how tight they may be, will no
longer hold their molecular secrets so tightly.
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